ArthroplastyJIICRBCSTKANCT04822259
Evaluate the Performance of JOURNEY II CR and JOURNEY II BCS in TKA Populations
A study testing JOURNEY II BCS Total Knee System and JOURNEY II CR Total Knee System in people with Arthroplasty and Replacement, run by Smith & Nephew, Inc. at 5 sites in 3 countries.
Trial summary
Background: The JOURNEY II BCS Total Knee System (JOURNEY II Bi-cruciate Stabilized Total Knee System) consists of femoral component made from oxidized zirconium (OXINIUM) The JOURNEY II CR Total Knee System (JOURNEY II Cruciate Retaining Total Knee System ) consists of femoral component made from oxidized zirconium… Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Arthroplasty, Replacement, Knee
- What is being tested?
- JOURNEY II BCS Total Knee System and JOURNEY II CR Total Knee System
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- 5 sitesin 3 countries
- Study dates
- 28 Aug 2022to 31 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Subjects with degenerative osteoarthritis.
- Subject is planning to have bilateral Total Knee Arthroplasty (TKA) using JOURNEY II BCS \& CR or have unilateral TKA using JOURNEY II BCS or JOURNEY II CR.*
- Subject is able and willing to provide voluntary consent to study participation.
- Subject is 18-80 years old (inclusive).
- [ Bilateral cases can be simultaneous bilateral or staged bilateral (which an interval of 6-8 weeks apart between both knees)]
Who cannot join
- Subjects with rheumatoid arthritis/inflammatory arthritis, posttraumatic arthritis.
- Previous surgeries including High Tibial Osteotomy (HTO), Unicondylar Knee Arthroplasty (UKA) or Total Knee Arthroplasty (TKA) on the subject knee.
- Subject is pregnant or breast feeding or those at a child-bearing age planning to become pregnant during the follow up.
- Subject does not meet the indication or is contraindicated for JOURNEY II BCS \& JOURNEY II CR's Instructions For Use (IFU).
Trial locations and contacts
5 sites in 3 countries.
5 sites in 3 countries
China2 sites
Peking University Third Hospital
Beijing, 100083
Prince of Wales Hospital
Hong Kong
India2 sites
Aster RV Hospital, Bangalore
Bengaluru, Karnataka, 560078
Noble Hospital & Ruby Hall Clinic
Pune, Maharashtra, 411001
About this study
Official title: A Prospective Multi-Centre Study in Patients Undergoing Total Knee Replacement With JOURNEY II BCS and CR Total Knee System
Background:
The JOURNEY II BCS Total Knee System (JOURNEY II Bi-cruciate Stabilized Total Knee System) consists of femoral component made from oxidized zirconium (OXINIUM)
Read more
The JOURNEY II CR Total Knee System (JOURNEY II Cruciate Retaining Total Knee System ) consists of femoral component made from oxidized zirconium (OXINIUM)
Purpose:
Post-market evidence generation for JOURNEY II BCS and JOURNEY II CR Total Knee System
Objectives:
- Evaluate the performance of JOURNEY II TKA in Asia-Pacific (APAC) patient populations
- Establish the equivalent performance between JOURNEY II BCS and JOURNEY II CR to support adoption of JOURNEY II CR
Research participants / locations:
A total of at least 176 knees' information will be collected in up to 10 sites. There will be at least eighty-eight (88) knees for JOURNEY II CR TKA group and at least 88 knees for JOURNEY II BCS TKA group.
- Conditions
- Arthroplasty, Replacement, Knee
- Being tested
- JOURNEY II BCS Total Knee System, JOURNEY II CR Total Knee System
- Keywords
- Osteoarthritis, Total knee arthroplasty (TKA), Cruciate Retaining (CR), Bi-cruciate Stabilized (BCS)
- Medical subject headings
- Osteoarthritis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
JOURNEY II BCS Total Knee SystemDevice
Undergoing Total Knee Replacement(resurfaced patella) with JOURNEY II BCS Total Knee System
JOURNEY II CR Total Knee SystemDevice
Undergoing Total Knee Replacement(resurfaced patella) with JOURNEY II CR Total Knee System
| Study group | Role | What they receive |
|---|---|---|
| JOURNEY II BCS TKA | Experimental | Undergoing Total Knee Replacement(resurfaced patella) with JOURNEY II BCS Total Knee System Receives: Device: JOURNEY II BCS Total Knee System |
| JOURNEY II CR TKA | Experimental | Undergoing Total Knee Replacement(resurfaced patella) with JOURNEY II CR Total Knee System Receives: Device: JOURNEY II CR Total Knee System |
What is being measured
The primary outcome is the main question the study is designed to answer.
Oxford Knee Score (OKS) at 2 years
The Oxford Knee Score (OKS) is a Patient Reported Outcome (PRO) questionnaire that was developed to specifically assess the patient's perspective of outcome following Total Knee Arthroplasty (TKA). The OKS is a patient self-completion PRO containing 12 equally weighted questions on activities of daily living. The OKS has been developed and validated specifically to assess perceived function and pain answered on a Likert scale after TKA. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome.
Measured: 2 years
Secondary outcomes (8)
Forgotten Joint Score (FJS)
The FJS comprises measures for the assessment of joint-specific patient reported outcomes. This questionnaire focuses on the study subject's awareness of the partially or fully replaced knee joint in everyday life. Joint awareness can be simply defined as any unintended perception of a joint. Subjects are asked to rate their awareness of their knee arthroplasty in 12 questions with a five-point Likert response format: "Never", "almost never", "seldom", "sometimes" and "mostly". The item scores are summed and linearly transformed in a 0 to 100 scale with a high value reflecting the ability of the subject to forget about the replaced knee joint during the activities of daily living.
Measured: 6 months, 1 year , 2 years, 3 years
Oxford Knee Score (OKS)
The Oxford Knee Score (OKS) is a Patient Reported Outcome (PRO) questionnaire that was developed to specifically assess the patient's perspective of outcome following Total Knee Arthroplasty (TKA). The OKS is a patient self-completion PRO containing 12 equally weighted questions on activities of daily living. The OKS has been developed and validated specifically to assess perceived function and pain answered on a Likert scale after TKA. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome.
Measured: Pre-Operative, 6 months, 1 year, 3 years
Knee Society Score (KSS)
The KSS is a validated tool that combines an objective physician-derived component with a subjective subject-derived component and consists of 4 separate sub-scales:
- An "Objective" Knee Score (seven items: 100 points)
- A Patient Satisfaction Score (five items: 40 points)
- A Patient Expectation Score (three items: 15 points)
- A Functional Knee Score (19 items: 100 points)
The Functional Knee Score is derived from assessments of walking and standing, standard activities, advanced activities, and discretionary activities. A higher number is a better outcome.
Measured: Pre-Operative, 6 months, 1 year, 2 years, 3 years
Patient Expectation
The patient expectation will be one single question which have 9 options to choose.
Patients need to choose at which level of activity he/she expect to recover after surgery.
The option will be from the most intensive activity to least intensive activity.
Measured: Pre-Operative
Patient Satisfaction
The patient satisfaction will be a corresponding question based on the expectation. It's a five -Likert options (from very satisfied to very dissatisfied) for patients to choose how satisfied he/she is with the surgery to meet the expectation.
Measured: 6 months, 1 year, 2 years, 3 years
Radiographic Assessment
Standard radiographic evaluation on antero-posterior (A/P) and lateral views shall be performed at the determined time point before and after surgery in order to identify any radiographic observations such as radiolucent lines around the implant components. The presence of radiolucent lines, osteolysis \& implant migration shall be recorded in the electronic Case Report Form (eCRF).
Measured: Pre-Operative, 6 months, 1 year, 2 years, 3 years
Timed Up and Go Test (TUG)
The Timed Up and Go Test assesses mobility, balance, walking ability, and fall risk in adults by measuring time, in seconds, that it takes the individual to stand from a chair, walk a distance of 10 feet (around 3 meters), walk back to the chair, and sit down. The subject will perform the test in their everyday footwear with their walking aid (cane, walker), if applicable [39]. The site will follow the guidelines provided by the Centers for Disease Control and Prevention recording the results on the form provided by the Sponsor
Measured: Pre-Operative, Immediate Post -op to 6 weeks, 6 months, 1 year
Star Excursion Balance Test (SEBT)
The SEBT has been introduced as a simple, reliable, and cost-effective alternative for instrumental devices to assess semi-dynamic balance. The SEBT is a functional test that incorporates a single-leg stance on 1 leg while trying to reach as far as possible with the opposite leg. Each patient performed 3 reaches (trials) in each of the 8 directions. The average of the maximum reach distance in each of the 8 directions was considered for analysis.
Measured: Pre-Operative, Immediate Post -op to 6 weeks, 6 months, 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Mar 2021
- Study start28 Aug 2022 (estimated)
- Primary completion31 Dec 2022 (estimated)
- Study completion31 Dec 2025 (estimated)
Why it stopped: Study design is not reasonable and sponsor decided to terminate the study. No patient enrolled by now
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ArthroplastyStudies of the same condition, open and under way.
- More trials run by Smith & Nephew, Inc.The sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Smith & Nephew, Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Astrid Yung, Study director, Smith & Nephew, Inc.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04822259
- Sponsor's protocol ID
- Journey II CR + BCS.2020.12
- Acronym
- JIICRBCSTKA
- Status last verified
- Jun 2022
- First submitted
- 26 Mar 2021
- Last updated
- 7 Jun 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Jun 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Prospective Multi-Centre Study in Patients Undergoing Total Knee Replacement With JOURNEY II BCS and CR Total Knee System
- ClinicalTrials.gov ID
- NCT04822259
- Acronym / sponsor ID
- JIICRBCSTKA / Journey II CR + BCS.2020.12
- Conditions
- Arthroplasty, Replacement, Knee
- Keywords
- Osteoarthritis, Total knee arthroplasty (TKA), Cruciate Retaining (CR), Bi-cruciate Stabilized (BCS)
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: Study design is not reasonable and sponsor decided to terminate the study. No patient enrolled by now
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Smith & Nephew, Inc.Industry (pharma, biotech, devices)
- Study start
- 28 Aug 2022 (estimated)
- Primary completion
- 31 Dec 2022 (estimated)
- Study completion
- 31 Dec 2025 (estimated)
- First posted
- 30 Mar 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background:
The JOURNEY II BCS Total Knee System (JOURNEY II Bi-cruciate Stabilized Total Knee System) consists of femoral component made from oxidized zirconium (OXINIUM)
The JOURNEY II CR Total Knee System (JOURNEY II Cruciate Retaining Total Knee System ) consists of femoral component made from oxidized zirconium (OXINIUM)
Purpose:
Post-market evidence generation for JOURNEY II BCS and JOURNEY II CR Total Knee System
Objectives:
- Evaluate the performance of JOURNEY II TKA in Asia-Pacific (APAC) patient populations
- Establish the equivalent performance between JOURNEY II BCS and JOURNEY II CR to support adoption of JOURNEY II CR
Research participants / locations:
A total of at least 176 knees' information will be collected in up to 10 sites. There will be at least eighty-eight (88) knees for JOURNEY II CR TKA group and at least 88 knees for JOURNEY II BCS TKA group.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| JOURNEY II BCS TKA | Experimental | Device: JOURNEY II BCS Total Knee SystemUndergoing Total Knee Replacement(resurfaced patella) with JOURNEY II BCS Total Knee System |
| JOURNEY II CR TKA | Experimental | Device: JOURNEY II CR Total Knee SystemUndergoing Total Knee Replacement(resurfaced patella) with JOURNEY II CR Total Knee System |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Subjects with degenerative osteoarthritis.
- Subject is planning to have bilateral Total Knee Arthroplasty (TKA) using JOURNEY II BCS \& CR or have unilateral TKA using JOURNEY II BCS or JOURNEY II CR.*
- Subject is able and willing to provide voluntary consent to study participation.
- Subject is 18-80 years old (inclusive).
- [ Bilateral cases can be simultaneous bilateral or staged bilateral (which an interval of 6-8 weeks apart between both knees)]
Key exclusion criteria (4 listed)
- Subjects with rheumatoid arthritis/inflammatory arthritis, posttraumatic arthritis.
- Previous surgeries including High Tibial Osteotomy (HTO), Unicondylar Knee Arthroplasty (UKA) or Total Knee Arthroplasty (TKA) on the subject knee.
- Subject is pregnant or breast feeding or those at a child-bearing age planning to become pregnant during the follow up.
- Subject does not meet the indication or is contraindicated for JOURNEY II BCS \& JOURNEY II CR's Instructions For Use (IFU).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| JOURNEY II BCS Total Knee SystemUndergoing Total Knee Replacement(resurfaced patella) with JOURNEY II BCS Total Knee System | Device | JOURNEY II BCS TKA |
| JOURNEY II CR Total Knee SystemUndergoing Total Knee Replacement(resurfaced patella) with JOURNEY II CR Total Knee System | Device | JOURNEY II CR TKA |
Primary outcome
Oxford Knee Score (OKS) at 2 years
Time frame: 2 years
The Oxford Knee Score (OKS) is a Patient Reported Outcome (PRO) questionnaire that was developed to specifically assess the patient's perspective of outcome following Total Knee Arthroplasty (TKA). The OKS is a patient self-completion PRO containing 12 equally weighted questions on activities of daily living. The OKS has been developed and validated specifically to assess perceived function and pain answered on a Likert scale after TKA. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome.
8 secondary outcomes
Forgotten Joint Score (FJS)
Time frame: 6 months, 1 year , 2 years, 3 years
Oxford Knee Score (OKS)
Time frame: Pre-Operative, 6 months, 1 year, 3 years
Knee Society Score (KSS)
Time frame: Pre-Operative, 6 months, 1 year, 2 years, 3 years
Patient Expectation
Time frame: Pre-Operative
Patient Satisfaction
Time frame: 6 months, 1 year, 2 years, 3 years
Radiographic Assessment
Time frame: Pre-Operative, 6 months, 1 year, 2 years, 3 years
Timed Up and Go Test (TUG)
Time frame: Pre-Operative, Immediate Post -op to 6 weeks, 6 months, 1 year
Star Excursion Balance Test (SEBT)
Time frame: Pre-Operative, Immediate Post -op to 6 weeks, 6 months, 1 year
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Jun 2022.
- Individual participant dataSharing planned: No
Related trials for Arthroplasty
Not yet recruiting
Is Routine Dental Clearance or Antibiotic Prophylaxis Before Dental Procedures Necessary in Total Joint Arthroplasty?
Elective Primary THA or TKA
Enrolling by invitation
Comparison of Functional Results of ADM X3-MoP Cup (Stryker) and a CoC Cup (Zimmer) in Young Patients
Arthroplasties, Hip Replacement
RecruitingPhase 3
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
Venous Thromboembolism (VTE)
Active, not recruiting
At Home, Digital Rehabilitation for Patients After Reverse Total Shoulder Arthroplasty
Arthroplasty, Replacement, Shoulder, Reverse Total Shoulder Arthroplasty
Recruiting
Intravenous Dexamethasone (0 vs 4 vs 8 mg) as an Adjunct to PENG Block for Postoperative Analgesia in Total Hip Arthroplasty
Osteoarthritis, Hip, Hip Osteoarthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Astrid Yung study director
Smith & Nephew, Inc.
5 sites in 3 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing JOURNEY II BCS Total Knee System and JOURNEY II CR Total Knee System in people with Arthroplasty and Replacement, run by Smith & Nephew, Inc. at 5 sites in 3 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 7 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 5 sites in China, India, Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Oxford Knee Score (OKS) at 2 years (time frame: 2 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jun 2022.